Molgramostim biosimilar (Reliance GeneMedix)

莫拉司亭生物类似药 (Reliance GeneMedix)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMolgramostim biosimilar (Reliance GeneMedix)
Drug Alias Name莫拉司亭生物仿制药 (Reliance GeneMedix)GM-CSF-Reliance GeneMedixNeustim
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesReliance Genemedix Ltd
China Registration ClassN/A

Develop Information

Active CompaniesReliance Genemedix Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA03
Related LinksN/A